Acceleron制药
XLRN

股本结构

单位：万股
公告日期 2021-11-04 2021-11-04 2021-09-30 2021-08-05 2021-08-05 2021-05-06
证券总股本 6115.58 6113.07 6111.57 6090.05 6077.76 6069.94
普通股本 6115.58 6113.07 6111.57 6090.05 6077.76 6069.94
优先股 未披露 未披露 未披露 未披露 未披露 未披露
其他 未披露 未披露 未披露 未披露 未披露 未披露
变动日期 2021-11-01 2021-09-30 2021-09-27 2021-07-31 2021-06-30 2021-04-30
注释：中概股证券总股本=普通股股本/ 存托凭证比例

历史变动

公告日期 变动后普通股本（万股） 变动后优先股（万股） 变动原因 变动日期
2021-11-04 6115.58 未披露 定期报告 2021-11-01
2021-11-04 6113.07 未披露
更多>>
From June 30, 2021 to September 30, 2021 Exercise of stock options Vesting of restricted stock units, net of shares withheld for taxes Issuance of common stock related to ESPP
2021-09-30
2021-09-30 6111.57 未披露 定期报告 2021-09-27
2021-08-05 6090.05 未披露 定期报告 2021-07-31
2021-08-05 6077.76 未披露
更多>>
From March 31, 2021 to June 30, 2021 Exercise of stock options Vesting of restricted stock units, net of shares withheld for taxes
2021-06-30
2021-05-06 6069.94 未披露 定期报告 2021-04-30
2021-04-22 6069.77 未披露 定期报告 2021-04-19
2021-05-06 6063.85 未披露
更多>>
From December 31, 2020 to March 31, 2021 Exercise of stock options Vesting of restricted stock units, net of shares withheld for taxes Issuance of common stock related to ESPP
2021-03-31
2021-02-25 6054.99 未披露 定期报告 2021-01-31
2021-02-25 6038.39 未披露
更多>>
From December 31,2019 to December 31,2020 Issuance of common stock net of expense $505 Exercise of stock options Vesting of restricted stock units,net of shares withheld for taxes Issuance of common stock related to ESPP Net exercise of warrants to purchase common stock
2020-12-31
2020-11-05 6025.20 未披露 定期报告 2020-10-31
2020-11-05 6005.20 未披露
更多>>
From June 30, 2020 to September 30, 2020 Issuance of common stock net of expense $505 Exercise of stock options Vesting of restricted stock units,net of shares withheld for taxes Issuance of common stock related to ESPP Net exercise of warrants to purchase common stock
2020-09-30
2020-08-06 5989.68 未披露 定期报告 2020-07-31
2020-07-06 5838.48 未披露
更多>>
1.Common stock offered by the company 4,864,864 shares of common stock 2.The number of shares of common stock to be outstanding after the offering is based on 53,519,920 shares of common stock outstanding as of March 31, 2020
2020-07-06
2020-08-06 5416.67 未披露
更多>>
From March 31, 2020 to June 30, 2020 Exercise of stock options Vesting of restricted stock units, net of shares withheld for taxes
2020-06-30
2020-05-11 5382.46 未披露 定期报告 2020-04-30
2020-04-16 5352.31 未披露 定期报告 2020-04-07
2020-05-11 5351.99 未披露
更多>>
From December 31, 2019 to March 31, 2020 Exercise of stock options Vesting of restricted stock units, net of shares withheld for taxes Issuance of common stock related to ESPP
2020-03-31
2020-02-27 5333.73 未披露 定期报告 2020-01-31
2020-02-27 5312.36 未披露
更多>>
From December 31, 2018 to December 31, 2019 Issuance of common stock, net of expense $500 Exercise of stock options Vesting of restricted stock units, net of shares withheld for taxes Issuance of common stock related to ESPP
2019-12-31
2019-11-06 5308.18 未披露 定期报告 2019-10-31
2019-11-06 5302.71 未披露
更多>>
from June 30, 2019 to September 30, 2019 Exercise of stock options Vesting of restricted stock units, net Issuance of common stock related to ESPP
2019-09-30
2019-08-05 5283.36 未披露 定期报告 2019-07-31
2019-08-05 5275.29 未披露
更多>>
from April 1, 2019 to June 30,2019 Exercise of stock options Vesting of restricted stock units
2019-06-30
2019-05-09 5268.57 未披露 定期报告 2019-04-30
2019-04-12 5268.43 未披露 定期报告 2019-04-09
2019-05-09 5254.21 未披露
更多>>
from December 31, 2018 to March 31, 2019 Issuance of common stock, net of expense $500 Exercise of stock options Vesting of restricted stock units Issuance of common stock related to ESPP
2019-03-31
2019-02-27 5169.05 未披露 定期报告 2019-01-31
2019-02-27 4626.07 未披露
更多>>
from December 31, 2017 to December 31, 2018 Exercise of stock options Vesting of restricted stock units Issuance of common stock related to ESPP Net exercise of warrants to purchase common stock
2018-12-31
2018-10-30 4619.03 未披露 定期报告 2018-10-23
2018-10-30 4618.55 未披露 定期报告 2018-09-30
2018-08-02 4600.25 未披露 定期报告 2018-07-31
2018-08-02 4584.51 未披露 定期报告 2018-06-30
2018-05-08 4577.53 未披露 定期报告 2018-04-30
2018-04-13 4576.53 未披露 定期报告 2018-04-09
2018-05-08 4572.30 未披露 定期报告 2018-03-31
2018-02-27 4541.91 未披露 定期报告 2018-01-31
2018-02-27 4526.12 未披露
更多>>
from December 31, 2016 to December 31, 2017 Issuance of common stock, net of expenses of $397 Exercise of stock options Vesting of restricted stock units Issuance of common stock related to ESPP Net exercise of warrants to purchase common stock
2017-12-31
2017-11-07 4523.50 未披露
更多>>
On October 4, 2017, in connection with the public offering of common stock on September 20, 2017, the underwriters of the Company's public offering fully exercised their over-allotment option to purchase an additional 810,810 shares of the Company's common stock at the public offering price of $37.00 per share, less underwriting discounts and commissions, resulting in additional net proceeds of approximately $28.2 million.
2017-10-31
2017-11-07 4441.47 未披露
更多>>
On September 25, 2017, the Company completed its underwritten public offering of 5,405,406 shares of common stock at a public offering price of $37.00 per share. The aggregate net proceeds received by the Company, after underwriting discounts and other estimated offering expenses, were approximately $187.6 million.
2017-09-30
2017-08-03 3868.51 未披露 定期报告 2017-07-31
2017-08-03 3863.65 未披露 定期报告 2017-06-30
2017-05-08 3861.78 未披露 定期报告 2017-04-30
2017-04-13 3861.39 未披露 定期报告 2017-04-04
2017-05-08 3859.61 未披露 定期报告 2017-03-31
2017-03-01 3839.47 未披露 定期报告 2017-01-31
2017-03-01 3825.18 未披露
更多>>
From December 31, 2015 to December 31, 2016 Issuance of common stock, net of expenses of $665 Exercise of stock options Issuance of common stock related to ESPP Net exercise of warrants to purchase common stock
2016-12-31
2016-11-03 3774.65 未披露 定期报告 2016-10-31
2016-11-03 3770.07 未披露 定期报告 2016-09-30
2016-08-04 3759.67 未披露 定期报告 2016-07-31
2016-08-04 3732.89 未披露 定期报告 2016-06-30
2016-05-05 3722.08 未披露 定期报告 2016-04-30
2016-04-15 3717.06 未披露 定期报告 2016-04-04
2016-05-05 3717.11 未披露 定期报告 2016-03-31
2016-02-25 3709.64 未披露 定期报告 2016-01-31
2016-02-25 3331.34 未披露
更多>>
from December 31, 2014 to December 31, 2015 Exercise of stock options Issuance of common stock related to ESPP Net exercise of warrants to purchase common stock
2015-12-31
2015-11-04 3325.32 未披露 定期报告 2015-10-31
2015-11-04 3319.76 未披露 定期报告 2015-09-30
2015-08-06 3305.91 未披露 定期报告 2015-07-31
2015-08-06 3298.11 未披露 定期报告 2015-06-30
2015-05-07 3281.20 未披露 定期报告 2015-04-30
2015-04-17 3279.09 未披露 定期报告 2015-04-13
2015-05-07 3276.41 未披露 定期报告 2015-03-31
2015-03-02 3264.43 未披露 定期报告 2015-01-31
2015-03-02 3243.20 未披露
更多>>
from December 31, 2013 to December 31, 2014 Issuance of common stock net of expenses of $554 Exercise of stock options Net exercise of warrants to purchase common stock Exercise of warrants to purchase common stock
2014-12-31
2014-11-07 3225.32 未披露 定期报告 2014-10-31
2014-11-07 3206.29 未披露 定期报告 2014-09-30
2014-08-12 3179.71 未披露 定期报告 2014-07-31
2014-08-12 3172.25 未披露 定期报告 2014-06-30
2014-05-15 3145.58 未披露 定期报告 2014-04-30
2014-04-30 3145.04 未披露 定期报告 2014-04-21
2014-05-15 3133.91 未披露 定期报告 2014-03-31
2014-03-17 3116.03 未披露 定期报告 2014-01-31
2014-03-17 2834.86 未披露
更多>>
from December 31, 2012 to December 31, 2013 Exercise of warrants to purchase convertible preferred stock Conversion of redeemable convertible preferred stock into common stock Repurchase and retirement of redeemable convertible preferred stock Issuance of common stock in connection with initial public offering and private placement, net of issuance costs of $2,692 Exercise of stock options Exercise of warrants to purchase common stock
2013-12-31
2013-11-14 2807.80 未披露 定期报告 2013-10-31
2013-11-14 2806.96 未披露
更多>>
Upon the closing of the IPO, all outstanding shares of convertible preferred stock converted into 18,516,993 shares of common stock and warrants exercisable for convertible preferred stock were automatically converted into warrants exercisable for 141,370 shares of common stock, resulting in the reclassification of the related convertible preferred stock warrant liability of $2.0 million to additional paid-in capital. Additionally, the Company is now authorized to issue 175,000,000 shares of common stock and 25,000,000 shares of undesignated preferred stock.
2013-09-30
2013-09-19 2654.42 未披露
更多>>
A 1-for-4 reverse stock split of the Company's common stock and redeemable convertible preferred stock, which was effective on September 5, 2013; the conversion of all 18,029,560 outstanding shares of our preferred stock into 18,516,993 shares of common stock upon the closing of this offering; the conversion of outstanding warrants exercisable for 141,370 shares of preferred stock into warrants exercisable for 141,370 shares of common stock;
2013-09-19
2013-09-06 244.72 未披露
更多>>
A 1-for-4 reverse stock split of the Company's common stock and redeemable convertible preferred stock, which was effective on September 5, 2013
2013-09-06
2013-08-20 978.89 7211.87
更多>>
from December 31, 2012 to June 30, 2013 Repurchase and retirement of redeemable convertible preferred stock Exercise of stock options Exercise of warrants to purchase convertible preferred stock
2013-06-30
2013-08-09 974.87 7211.87
更多>>
from December 31, 2012 to March 31, 2013 Repurchase and retirement of redeemable convertible preferred stock Exercise of stock options Exercise of warrants to purchase convertible preferred stock
2013-03-31
From June 30, 2021 to September 30, 2021 Exercise of stock options Vesting of restricted stock units, net of shares withheld for taxes Issuance of common stock related to ESPP
From March 31, 2021 to June 30, 2021 Exercise of stock options Vesting of restricted stock units, net of shares withheld for taxes
From December 31, 2020 to March 31, 2021 Exercise of stock options Vesting of restricted stock units, net of shares withheld for taxes Issuance of common stock related to ESPP
From December 31,2019 to December 31,2020 Issuance of common stock net of expense $505 Exercise of stock options Vesting of restricted stock units,net of shares withheld for taxes Issuance of common stock related to ESPP Net exercise of warrants to purchase common stock
From June 30, 2020 to September 30, 2020 Issuance of common stock net of expense $505 Exercise of stock options Vesting of restricted stock units,net of shares withheld for taxes Issuance of common stock related to ESPP Net exercise of warrants to purchase common stock
1.Common stock offered by the company 4,864,864 shares of common stock 2.The number of shares of common stock to be outstanding after the offering is based on 53,519,920 shares of common stock outstanding as of March 31, 2020
From March 31, 2020 to June 30, 2020 Exercise of stock options Vesting of restricted stock units, net of shares withheld for taxes
From December 31, 2019 to March 31, 2020 Exercise of stock options Vesting of restricted stock units, net of shares withheld for taxes Issuance of common stock related to ESPP
From December 31, 2018 to December 31, 2019 Issuance of common stock, net of expense $500 Exercise of stock options Vesting of restricted stock units, net of shares withheld for taxes Issuance of common stock related to ESPP
from June 30, 2019 to September 30, 2019 Exercise of stock options Vesting of restricted stock units, net Issuance of common stock related to ESPP
from April 1, 2019 to June 30,2019 Exercise of stock options Vesting of restricted stock units
from December 31, 2018 to March 31, 2019 Issuance of common stock, net of expense $500 Exercise of stock options Vesting of restricted stock units Issuance of common stock related to ESPP
from December 31, 2017 to December 31, 2018 Exercise of stock options Vesting of restricted stock units Issuance of common stock related to ESPP Net exercise of warrants to purchase common stock
from December 31, 2016 to December 31, 2017 Issuance of common stock, net of expenses of $397 Exercise of stock options Vesting of restricted stock units Issuance of common stock related to ESPP Net exercise of warrants to purchase common stock
On October 4, 2017, in connection with the public offering of common stock on September 20, 2017, the underwriters of the Company's public offering fully exercised their over-allotment option to purchase an additional 810,810 shares of the Company's common stock at the public offering price of $37.00 per share, less underwriting discounts and commissions, resulting in additional net proceeds of approximately $28.2 million.
On September 25, 2017, the Company completed its underwritten public offering of 5,405,406 shares of common stock at a public offering price of $37.00 per share. The aggregate net proceeds received by the Company, after underwriting discounts and other estimated offering expenses, were approximately $187.6 million.
From December 31, 2015 to December 31, 2016 Issuance of common stock, net of expenses of $665 Exercise of stock options Issuance of common stock related to ESPP Net exercise of warrants to purchase common stock
from December 31, 2014 to December 31, 2015 Exercise of stock options Issuance of common stock related to ESPP Net exercise of warrants to purchase common stock
from December 31, 2013 to December 31, 2014 Issuance of common stock net of expenses of $554 Exercise of stock options Net exercise of warrants to purchase common stock Exercise of warrants to purchase common stock
from December 31, 2012 to December 31, 2013 Exercise of warrants to purchase convertible preferred stock Conversion of redeemable convertible preferred stock into common stock Repurchase and retirement of redeemable convertible preferred stock Issuance of common stock in connection with initial public offering and private placement, net of issuance costs of $2,692 Exercise of stock options Exercise of warrants to purchase common stock
Upon the closing of the IPO, all outstanding shares of convertible preferred stock converted into 18,516,993 shares of common stock and warrants exercisable for convertible preferred stock were automatically converted into warrants exercisable for 141,370 shares of common stock, resulting in the reclassification of the related convertible preferred stock warrant liability of $2.0 million to additional paid-in capital. Additionally, the Company is now authorized to issue 175,000,000 shares of common stock and 25,000,000 shares of undesignated preferred stock.
A 1-for-4 reverse stock split of the Company's common stock and redeemable convertible preferred stock, which was effective on September 5, 2013; the conversion of all 18,029,560 outstanding shares of our preferred stock into 18,516,993 shares of common stock upon the closing of this offering; the conversion of outstanding warrants exercisable for 141,370 shares of preferred stock into warrants exercisable for 141,370 shares of common stock;
A 1-for-4 reverse stock split of the Company's common stock and redeemable convertible preferred stock, which was effective on September 5, 2013
from December 31, 2012 to June 30, 2013 Repurchase and retirement of redeemable convertible preferred stock Exercise of stock options Exercise of warrants to purchase convertible preferred stock
from December 31, 2012 to March 31, 2013 Repurchase and retirement of redeemable convertible preferred stock Exercise of stock options Exercise of warrants to purchase convertible preferred stock
同花顺个股页面 | 模拟炒股 | 股民学校 | 手机炒股| 联系我们

免责声明:本信息由同花顺金融研究中心提供，仅供参考，同花顺金融研究中心力求但不保证数据的完全准确，如有错漏请以中国证监会指定上市公司信息披露媒体为准，同花顺金融研究中心不对因该资料全部或部分内容而引致的盈亏承担任何责任。用户个人对服务的使用承担风险。同花顺对此不作任何类型的担保。同花顺不担保服务一定能满足用户的要求，也不担保服务不会受中断，对服务的及时性，安全性，出错发生都不作担保。同花顺对在同花顺上得到的任何信息服务或交易进程不作担保。同花顺提供的包括同花顺理财的所有文章，数据，不构成任何的投资建议，用户查看或依据这些内容所进行的任何行为造成的风险和结果都自行负责，与同花顺无关。

【免责声明】本产品中的行情数据及资讯信息来源于第三方，长江证券不对收集数据的版权、真实性、准确性及传输过程中发生的传送错误承担法律责任。本内容仅供参考，不作为投资决策依据，长江证券不对因据此操作产生的盈亏承担任何责任。投资有风险，入市需谨慎。